IDO1 and cancer: Previous work has shown indoleamine 2,3-dioxygenase (IDO) and Ras homolog gene family member C (RhoC) to be promising antigen targets for inclusion in vaccines against multiple cancer forms (Wenandy et al., 2008; Sørensen et al., 2009).